Statistics

Total Visits

Views
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer11

Select a period of time:

Number of views in the range

Views
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer5

Views

Views
November 20230
December 20230
January 20240
February 20241
March 20240
April 20241
May 20243
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
 

Top cities views

Views
Ashburn1
Chicago1
Fort Worth1